Fisher Owain, Gates Zoe, Parkes Edward, Shakespeare Joanna, Goodyear Steven J, Imray Christopher H E, Benson Ruth A
Department of Vascular Surgery, University Hospital Coventry and Warwickshire, Coventry, UK.
Department of Vascular Surgery, University Hospital Coventry and Warwickshire, Coventry, UK.
Ann Vasc Surg. 2019 Nov;61:334-340. doi: 10.1016/j.avsg.2019.05.047. Epub 2019 Aug 5.
Cardiopulmonary exercise testing (CPET) provides an objective assessment of functional capacity and fitness. It can be used to guide decision making prior to major vascular surgery. The EVAR-2 trial suggested that endovascular aneurysm repair (EVAR) in patients unfit for open repair failed to provide a significant survival advantage over nonsurgical management. The aim of this study is to assess contemporary survival differences between patients with poor CPET measures who underwent EVAR or were not offered surgical intervention.
A prospectively maintained database of CPET results of patients considered for elective infrarenal aortic aneurysm repair were interrogated. Anaerobic threshold (AT) of <11 mL/min/kg was used to indicate poor physical fitness. Hospital electronic records were then reviewed for perioperative, reintervention, and long-term outcomes.
Between November 2007 and October 2017, 532 aortic aneurysm repairs were undertaken, of which 376 underwent preoperative CPET. Seventy patients were identified as having an AT <11 mL/min/kg. Thirty-seven patients underwent EVAR and 33 were managed nonsurgically. All-cause survival at 1, 3, and 5 years for those patients who underwent EVAR was 97%, 92%, and 81%, respectively. For those not offered surgical intervention survival at the same points was 72%, 48%, and 24% [hazard ratio, HR = 5.13 (1.67-15.82), P = 0.004]. Aneurysm-specific survival at 1, 3, and 5 years for those patients who underwent EVAR was 97%, 94%, and 94%, respectively. Survival at the same time points for those not offered surgical intervention was 90%, 69%, and 39%, respectively [HR = 7.48 (1.37-40.82), P = 0.02].
In this small, retrospective, single-center, nonrandomized cohort, EVAR may provide a survival advantage in patients with poor physical fitness identified via CPET. Randomized studies with current generation EVAR are required to validate the results shown here.
心肺运动试验(CPET)可对功能能力和健康状况进行客观评估。它可用于指导重大血管手术前的决策制定。EVAR - 2试验表明,对于不适合开放修复的患者,血管内动脉瘤修复(EVAR)与非手术治疗相比,未能提供显著的生存优势。本研究的目的是评估接受EVAR或未接受手术干预的CPET测量结果不佳的患者之间的当代生存差异。
对一个前瞻性维护的数据库进行查询,该数据库包含考虑进行择期肾下腹主动脉瘤修复的患者的CPET结果。无氧阈值(AT)<11 mL/min/kg被用于表明身体状况不佳。然后查阅医院电子记录以获取围手术期、再次干预和长期结果。
在2007年11月至2017年10月期间,共进行了532例主动脉瘤修复手术,其中376例接受了术前CPET检查。70例患者被确定为AT<11 mL/min/kg。37例患者接受了EVAR治疗,33例接受了非手术治疗。接受EVAR治疗的患者在1年、3年和5年的全因生存率分别为97%、92%和81%。对于未接受手术干预的患者,相同时间点的生存率分别为72%、48%和24%[风险比,HR = 5.13(1.67 - 15.82),P = 0.004]。接受EVAR治疗的患者在1年、3年和5年的动脉瘤特异性生存率分别为97%、94%和94%。未接受手术干预的患者在相同时间点的生存率分别为90%、69%和39%[HR = 7.48(1.37 - 40.82),P = 0.02]。
在这个小型、回顾性、单中心、非随机队列研究中,EVAR可能为通过CPET确定的身体状况不佳的患者提供生存优势。需要进行关于当代EVAR的随机研究来验证此处显示的结果。